Haplotype Subject number = 214; Allele number = 428 (allelic frequency) OS DFS DDFS Event number (frequency) Hazard ratio (95% CI) aHR (95% CI)
Event number (frequency) Hazard ratio (95% CI) aHR (95% CI)
Event number (frequency) Hazard ratio (95% CI) aHR (95% CI)
AASA versus non-AASA (17.1% versus 82.9%) Total 27 (10.3 %) 1.9 (1.1–3.5) 2.1 (1.2–3.9) 0.03 0.01 51 (23.8%) 1.9 (1.2–3.0) 2.0 (1.3–3.2) 0.004 0.002 41 (19.2%) 1.8 (1.1–3.0) 2.0 (1.2–3.2) 0.02 0.008 Premenopausal 2.9 (1.5–5.7) 3.3 (1.6–6.8) 0.002 0.001 2.4 (1.4–3.9) 2.5 (1.5–4.2) 0.001 0.0008 2.6 (1.5–4.6) 2.9 (1.6–5.3) 0.0009 0.0004 Postmenopausal 0.6 (0.1–2.7) 0.7 (0.2–3.4) 0.53 0.71 1.2 (0.5–2.9) 1.4 (0.6–3.6) 0.72 0.44 0.8 (0.3–2.2) 0.9 (0.3–2.6) 0.60 0.81 AASC versus non-AASC (8.9% versus 91.1%) Total 27 (10.3 %) 2.0 (0.9–4.2) 2.9 (1.3–6.3) 0.08 0.008 51 (23.8%) 1.3 (0.7–2.5) 1.5 (0.8–2.9) 0.36 0.22 41 (19.2%) 1.3 (0.6–2.5) 1.6 (0.8–3.4) 0.51 0.18 Premenopausal 1.5 (0.5–4.1) 2.1 (0.7–6.4) 0.48 0.18 1.0 (0.4–2.4) 1.1 (0.4–2.7) 0.93 0.86 1.1 (0.4–2.7) 1.4 (0.5–3.6) 0.89 0.54 Postmenopausal 3.3 (1.1–10.0) 4.4 (1.4–14.1) 0.04 0.01 2.2 (0.8–5.6) 3.1 (1.1–8.3) 0.11 0.03 1.7 (0.6–5.0) 2.5 (0.8–7.6) 0.31 0.10 CASA versus non-CASA (11.9% versus 88.1%) Total 0.6 (0.2–1.6) 0.6 (0.2–1.6) 0.30 0.31 0.8 (0.4–1.5) 0.8 (0.4–1.6) 0.48 0.58 0.8 (0.4–1.7) 0.8 (0.4–1.7) 0.62 0.58 Premenopausal 0.6 (0.2–2.1) 0.6 (0.2–2.1) 0.45 0.45 0.8 (0.3–1.7) 0.8 (0.4–1.8) 0.49 0.60 0.7 (0.3–1.8) 0.7 (0.3–1.7) 0.70 0.40 Postmenopausal 0.5 (0.1–3.5) 0.5 (0.1–4.1) 0.45 0.53 0.8 (0.3–2.7) 0.8 (0.2–2.7) 0.75 0.69 1.1 (0.3–3.8) 1.1 (0.3–4.2) 0.83 0.85 CCLA versus non-CCLA (41.1% versus 58.9%) Total 0.6 (0.3–1.1) 0.6 (0.3–1.0) 0.07 0.06 0.8 (0.5–1.2) 0.8 (0.5–1.2) 0.28 0.22 0.8 (0.5–1.3) 0.8 (0.5–1.2) 0.33 0.27 Premenopausal 0.5 (0.3–1.1) 0.6 (0.3–1.2) 0.10 0.14 0.7 (0.4–1.2) 0.8 (0.5–1.3) 0.22 0.30 0.7 (0.4–1.2) 0.7 (0.4–1.3) 0.20 0.28 Postmenopausal 0.7 (0.3–1.9) 0.6 (0.2–1.6) 0.46 0.33 0.9 (0.5–1.9) 0.8 (0.4–1.6) 0.88 0.49 1.0 (0.5–2.2) 0.8 (0.4–1.8) 0.91 0.64 CCLC versus non-CCLC (8.9% versus 91.1%) Total 0.8 (0.3–2.1) 0.6 (0.2–1.6) 0.62 0.28 0.6 (0.2–1.3) 0.4 (0.2–1.0) 0.18 0.05 0.5 (0.2–1.3) 0.4 (0.1–1.0) 0.14 0.05 Premenopausal 0.6 (0.1–2.3) 0.3 (0.1–1.5) 0.42 0.16 0.5 (0.2–1.5) 0.4 (0.1–1.2) 0.22 0.10 0.3 (0.1–1.4) 0.3 (0.1–1.1) 0.14 0.07 Postmenopausal 1.2 (0.3–5.4) 1.0 (0.2–4.5) 0.78 0.99 0.7 (0.2–2.7) 0.5 (0.1–2.4) 0.56 0.42 0.7 (0.2–3.1) 0.7 (0.2–2.9) 0.67 0.60 CCSA versus non-CCSA (7.5% versus 92.5%) Total 1.9 (0.9–4.2) 1.8 (0.8–4.0) 0.11 0.15 1.1 (0.5–2.2) 1.1 (0.5–2.4) 0.85 0.72 1.4 (0.7–2.9) 1.4 (0.7–3.0) 0.35 0.35 Premenopausal 1.8 (0.6–5.1) 1.6 (0.6–4.8) 0.27 0.37 1.1 (0.4–2.8) 1.0 (0.4–2.5) 0.81 0.99 1.4 (0.6–3.6) 1.3 (0.5–3.3) 0.44 0.63 Postmenopausal 2.1 (0.6–7.3) 1.8 (0.5–6.3) 0.23 0.36 1.1 (0.3–3.5) 1.1 (0.3–3.8) 0.93 0.85 1.4 (0.4–4.6) 1.4 (0.4–4.7) 0.59 0.61